Quantum BioPharma Ltd.

QNTM · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$4,748-$9,766-$8,740-$5,456
Dep. & Amort.$145$141$130$113
Deferred Tax$0$0$0$0
Stock-Based Comp.$996$850$291-$82
Change in WC$2,131-$1,083$284$7,370
Other Non-Cash-$247$7,909$3,774-$2,780
Operating Cash Flow-$1,721-$1,949-$4,261-$836
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$1,347-$1,447-$2,800-$4,207
Inv. Sales/Matur.$1,756$86$1,450$5,451
Other Inv. Act.$0$0$0$0
Investing Cash Flow$408-$1,361-$1,350$1,244
Financing Activities
Debt Repay.$265$1,929$3,088$982
Stock Issued$0$0$0$1,485
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$3-$640$46$0
Financing Cash Flow$261$1,290$3,133$2,468
Forex Effect$0$0$0$0
Net Chg. in Cash-$1,052-$2,021-$2,478$2,876
Supplemental Information
Beg. Cash$1,498$3,518$5,996$3,120
End Cash$446$1,498$3,518$5,996
Free Cash Flow-$1,721-$1,949-$4,261-$836
Quantum BioPharma Ltd. (QNTM) Financial Statements & Key Stats | AlphaPilot